USD 3.12
(-11.36%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 65.9 Million USD | -10.21% |
2022 | 73.39 Million USD | 17.3% |
2021 | 62.56 Million USD | 35.27% |
2020 | 46.25 Million USD | 67.68% |
2019 | 27.58 Million USD | 1707.54% |
2018 | 1.52 Million USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q3 | 20.56 Million USD | -4.31% |
2024 Q1 | 17.65 Million USD | 6.9% |
2024 Q2 | 21.48 Million USD | 21.7% |
2023 Q1 | 15.47 Million USD | -18.47% |
2023 FY | 65.9 Million USD | -10.21% |
2023 Q3 | 15.42 Million USD | -16.58% |
2023 Q2 | 18.48 Million USD | 19.46% |
2023 Q4 | 16.51 Million USD | 7.1% |
2022 Q1 | 15.57 Million USD | -17.98% |
2022 Q2 | 19.21 Million USD | 23.38% |
2022 FY | 73.39 Million USD | 17.3% |
2022 Q4 | 18.98 Million USD | -3.24% |
2022 Q3 | 19.61 Million USD | 2.1% |
2021 Q2 | 16.51 Million USD | 32.71% |
2021 FY | 62.56 Million USD | 35.27% |
2021 Q4 | 18.98 Million USD | 29.86% |
2021 Q3 | 14.62 Million USD | -11.46% |
2021 Q1 | 12.44 Million USD | -20.52% |
2020 Q1 | 8.67 Million USD | -19.25% |
2020 Q4 | 15.65 Million USD | 54.46% |
2020 Q3 | 10.13 Million USD | -14.05% |
2020 Q2 | 11.79 Million USD | 36.01% |
2020 FY | 46.25 Million USD | 67.68% |
2019 FY | 27.58 Million USD | 1707.54% |
2019 Q4 | 10.73 Million USD | 0.0% |
2018 FY | 1.52 Million USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Abbott Laboratories | 40.1 Billion USD | 99.836% |
Allurion Technologies Inc. | 53.46 Million USD | -23.254% |
Artivion, Inc. | 354 Million USD | 81.384% |
Avanos Medical, Inc. | 673.3 Million USD | 90.212% |
Butterfly Network, Inc. | 65.9 Million USD | 0.0% |
Bio-Rad Laboratories, Inc. | 2.67 Billion USD | 97.533% |
Boston Scientific Corporation | 14.24 Billion USD | 99.537% |
Perspective Therapeutics, Inc. | 7.1 Million USD | -827.646% |
CONMED Corporation | 1.24 Billion USD | 94.69% |
Edwards Lifesciences Corporation | 6 Billion USD | 98.903% |
Paragon 28, Inc. | 216.38 Million USD | 69.546% |
Glaukos Corporation | 314.71 Million USD | 79.06% |
Globus Medical, Inc. | 1.56 Billion USD | 95.798% |
Inspire Medical Systems, Inc. | 624.79 Million USD | 89.453% |
Integer Holdings Corporation | 1.59 Billion USD | 95.873% |
Medtronic plc | 32.36 Billion USD | 99.796% |
Nevro Corp. | 425.17 Million USD | 84.5% |
Owlet, Inc. | 54.01 Million USD | -22.014% |
Penumbra, Inc. | 1.05 Billion USD | 93.774% |
Vicarious Surgical Inc. | - USD | -Infinity% |
Smith & Nephew plc | 5.54 Billion USD | 98.812% |
Sonendo, Inc. | 43.86 Million USD | -50.234% |
STERIS plc | 5.13 Billion USD | 98.718% |
Stryker Corporation | 20.49 Billion USD | 99.679% |
Vapotherm, Inc. | 68.66 Million USD | 4.032% |
Zimmer Biomet Holdings, Inc. | 7.39 Billion USD | 99.109% |